Skip to content

Preservation of total pelvic organ function based on intraoperative monitoring of the pelvic nerves and penile intracavernous pressure during radical prostatectomy: a prospective study

Preservation of total pelvic organ function based on intraoperative monitoring of the pelvic nerves and penile intracavernous pressure during radical prostatectomy: a prospective study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045545
Enrollment
Unknown
Registered
2021-04-19
Start date
2021-04-15
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Strong positive group:Radical prostatectomy
Non-strongly positive group:Intraoperative monitoring

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.Patients with pathologically confirmed low - and medium-risk prostate cancer (=18, urinary control function and defecation function basically normal; 2.Understand and voluntarily sign written informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with severe cardiopulmonary dysfunction or coagulation dysfunction that cannot be treated by surgery; 2.Patients with preoperative erectile dysfunction, urinary control and urination dysfunction; 3.Patients with pacemakers or other electrophysiological treatments; 4.Patients with previous history of abdominal and pelvic surgery or radiotherapy.Patients who underwent previous electroprostatectomy; 5.Patients with central and peripheral neuropathy; 6.Patients with severe anxiety, depression, mania or mental illness who are unable to cooperate with treatment and follow-up; 7.Patients with a history of other malignant tumors; 8.Patients with severe allergic constitution; 9.Patients who received prior endocrine therapy or radiotherapy for prostate cancer; 10.Patients whose physicians do not recommend neuromonitoring for other reasons.

Design outcomes

Primary

MeasureTime frame
Corpus cavernosum electromyography;Intra cavernous pressure;

Countries

China

Contacts

Public ContactZhang Xu

Chinese PLA General Hospital

xzhang@foxmail.com+86 13801350955

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026